Publications by authors named "S J Fey"

Oncolytic measles virus (MeV) is a promising anti-cancer treatment. However, the production of high titers of infectious MeV (typically 10-10 TCID per dose) is challenging because the virus is unstable under typical production conditions. The objective of this study was to investigate how the multiplicity of infection (MOI) and different media-a serum-containing medium (SCM), a serum-free medium (SFM) and two chemically defined media (CDM)-affect MeV production.

View Article and Find Full Text PDF

Pancreatic cancer is characterized by the prevalence of oncogenic mutations in KRAS. Previous studies have reported that altered KRAS gene dosage drives progression and metastasis in pancreatic cancer. While the role of oncogenic KRAS mutations is well characterized, the relevance of the partnering wild-type KRAS allele in pancreatic cancer is less well understood and controversial.

View Article and Find Full Text PDF

Stem cells play pivotal roles in maintaining intestinal homeostasis, orchestrating regeneration, and in key steps of colorectal cancer (CRC) initiation and progression. Intriguingly, adult stem cells are reduced during many of these processes. On the contrary, primitive fetal programs, commonly detected in development, emerge during tissue repair, CRC metastasis, and therapy resistance.

View Article and Find Full Text PDF

Predators have a key role in structuring ecosystems. However, predator loss is accelerating globally, and predator mass-mortality events (MMEs)-rapid large-scale die-offs-are now emblematic of the Anthropocene epoch. Owing to their rare and unpredictable nature, we lack an understanding of how MMEs immediately impact ecosystems.

View Article and Find Full Text PDF
Article Synopsis
  • Oncogenic KRAS mutations are known to drive cancer formation, and recent studies show that changes in KRAS gene dosage, including loss of the normal allele, are common in these cancers.
  • Researchers developed a mouse model of colorectal cancer to investigate the effects of deleting wild-type Kras along with the oncogenic variant.
  • The absence of wild-type Kras enhances tumor growth and signaling pathways while also making tumors more responsive to certain therapies, indicating its important role in cancer progression and treatment outcomes in KRAS-mutant colorectal cancer.
View Article and Find Full Text PDF